According to the report published by Visiongain, the Transfection Reagent and Equipment market is estimated to be valued at approximately USD xx million in 2019 and is expected to grow at a CAGR of around xx% between 2020 and 2030. Transfection is the mechanism by which nuclear acids are inserted by non-viral approaches into eukaryotic cells. This gene transfer technology allows gene roles and protein expression to be studied in a cellular setting utilizing different chemical or physical approaches. Transfection uses have been significantly expanded by the design of reporter gene systems and selection procedures for safe preservation and expression of transfected DNA. Assay based technology provides the basis for the study of mammalian promoters and enhancer sequences, transacting proteins, such as transcription factors, mRNA processing, and protein, along with an extensive range of transfectional reagents. Development of recombinant technology & proteomics and the rising use by academic researchers of transfecting technology are some of the major developments that fuel market development. It is also planned that new reagents will be added to extend the use of transfection in various applications.
Transfection is one of the main research projects that lead to synthetic genetics studies. Transfections can lead to the development of abnormal cells and unstable morphologies, but the mechanism can also be used to research the composition of genetic makeup and, through a deliberate invasion, change cell structures. Transfection has a crucial role in biomonitoring through the facilitation of research analyzes and bio-authenticity studies for regulatory approval of biopharmaceuticals. It innovation is therefore likely to be seeing both market and sales growth with the growing popularity of biopharmaceutical goods. Moreover, recently, the biopharmaceutical sector has seen a major patent cliff, with a patent expiration for several blockbuster biologics. As a result, many businesses have started to invest in the development of biosimilar biologic alternative products to address the risk of income loss. Therefore, by increasing the adoption rate of transfection software, the patent cliff risk has greatly benefited the business.
Why you should buy Transfection Reagent and Equipment Market Forecast 2020-2030
Transfection Methods Such As Laserfection Or Optoinjection Are Estimated To Boost The Growth Of The Equipment Segment.
Most of the transfection reagents include transfection kits for stem cells, transfection kits for siRNA, transfection buffers and optimisation kits for transfections. Various transfection methods involve the use of different reagents and thereby produce substantial revenue for the product. In terms of revenues, the reagents sector dominated the market. According to rising market acceptance levels of these reagents, this segment is expected to become important over the forecast period. Electroportation and electro fusion systems include transfection equipment. The volume of genomics-based research & development projects and the introduction of easy to use products like portable are rapidly rising. Owing to presence of expensive laser-based equipment used for different transfection methods such as laserfection or optoinjection are estimated to boost the growth of the equipment segment.
The Liposome Sector Is Expected To Post Notable CAGR During The Forecast Period
Livosomal transfer and particulate bombardment were closely followed in 2019 by electric company as the leading revenue share. Wide portfolios offered by large and emerging players for a range of electroporation solutions stimulate segment growth. In addition, the segment growth increases with a number of advantages, such as ease of use, variability and speed. The liposome sector is expected to post notable CAGR during the forecast period, with considerable participation in 2016. This method will likely be supported by a continued development of lipofection for increased in-vivo transfection efficiency.
The Income Generated From The Transfection Applications Is Projected To Significantly Increase, Contributing To Success On The Sector
In view of the increasing process volumes and the availability of a relatively large number of R&D projects, the income generated from the transfection applications is projected to significantly increase, contributing to success on the sector. Transfection reagents and devices studied are used in gene expression experiments, in the manufacture of proteins, in transgenic template development, in medicinal delivery, in biomedical research and in cancer research. The most prominent application segment in 2019 was gene expression studies. Expanding the genomic data pool and increasing emphasis on genomic information translation in clinical workflows lead to a significant share. Presence of a substantial number of ongoing research projects that aim at in-depth investigation of key mechanism, which underlie chromosomal anomalies, is also supplementing the growth of the segment.
North America was the market leader in 2019
Due to the presence of established biopharmaceuticals and genomics industries in the region, North America was the market leader in 2019. Among biological, cytological and oncological research institutions, there has been a heavy use of transfection technologies. Also leading to the development of the regional market is the existence of influential firms offering a variety of solutions to different end-useers in the area. The most rapid growth in the forecast period is expected in the Asia-Pacific region. Significant growth in the number of biopharmaceutical & clinical R&D programs, increasing medical research expenditure, and rising awareness regarding cytological and proteomic expressions are some of the key trends driving the regional market.
What is the future of the Transfection Reagent and Equipment market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 171 page report you will receive the following key information
• View Transfection Reagent and Equipment market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Transfection Reagent and Equipment revenue forecast
– Transfection Reagent and Equipment connections forecast
• Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Transfection Reagent and Equipment market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Transfection Reagent and Equipment sector
• Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Transfection Reagent and Equipment industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Transfection Reagent and Equipment submarkets with individual forecasts and analysis from 2020-2030.
– Method submarket forecast 2020-2030
– Application submarket forecast 2020-2030
– Product submarket forecast 2020-2030
• Learn about the market prospects for the leading Transfection Reagent and Equipment market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Transfection Reagent and Equipment revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Method Revenue Forecast 2020-2030
Electroporation revenue forecast 2020-2030
Liposomes revenue forecast 2020-2030
Particle Bombardment revenue forecast 2020-2030
Microinjection revenue forecast 2020-2030
Adenoviral Vectors revenue forecast 2020-2030
Direct Microinjection revenue forecast 2020-2030
Calcium phosphate revenue forecast 2020-2030
DEAE – dextran revenue forecast 2020-2030
Magnetic Beads revenue forecast 2020-2030
Activated Dendrimers revenue forecast 2020-2030
Laserfection revenue forecast 2020-2030
Other Methods revenue forecast 2020-2030
– Application Revenue Forecast 2020-2030
Gene Expression Studies revenue forecast 2020-2030
Protein Production revenue forecast 2020-2030
Transgenic Models revenue forecast 2020-2030
Therapeutic Delivery revenue forecast 2020-2030
Cancer Research revenue forecast 2020-2030
Biomedical Research revenue forecast 2020-2030
– Product Revenue Forecast 2020-2030
Reagents revenue forecast 2020-2030
Equipment revenue forecast 2020-2030
Other Products revenue forecast 2020-2030
• Understand the prospects for the 4 regional and the leading 12 national Transfection Reagent and Equipment markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Transfection Reagent and Equipment companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
• Explore the factors affecting Transfection Reagent and Equipment product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
• Identify who the leading companies are in the Transfection Reagent and Equipment industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Transfection Reagent and Equipment companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
The foreign demand for transfection reactives and equipment is projected to exhibit positive rate of growth in the next few years, largely due to recent developments in transfection engineering and the heavy effect on research and development activities on this sector by pharmaceutical and biotechnology organizations. The global reaction and equipment market also benefits from the newly established high-value alliances and partnerships, particularly between large pharmaceutical names and institutes of research, to boost drug discovery rates. The global demand for synthetic genes has seen and will probably continue to grow at a strong rate in the recent past. The study and growth efforts to combat cancer, an illness already highly prevalent in all countries, represent a significant part of this market.
Biotechnology firms, pharmaceutical companies, research institutes and educational institutions are the global market leading end users of transfection reagents and supplies. Viral, physical and biochemical are the main methods of transfection that this market can be segmented on. The video market would likely show a very positive growth trend in the next few years.
Leading Companies in the Global Transfection Reagent and Equipment Market
Merck KgaA
Thermo Fisher Scientific Inc
Promega Corporation
Mirus Bio LLC
EMD Millipore
Bio-Rad Laboratories Inc.
OriGene Technologies Inc
Lonza AG
Qiagen
F. Hoffmann-La Roche Ltd
Maxcyte, Inc.
Discover Information found nowhere else in this independent assessment of the Transfection Reagent and Equipment market
The Transfection Reagent and Equipment Market Forecast 2020-2030: Forecasts and Analysis By Method, By Application, By Product and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Transfection Reagent and Equipment sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030.
How the Transfection Reagent and Equipment Market Forecast 2020-2030: Forecasts and Analysis By Method, By Application, By Product and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Transfection Reagent and Equipment market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Transfection Reagent and Equipment sector and find out what its future market prospects are.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Transfection Reagent and Equipment Market Forecast 2020-2030: Forecasts and Analysis by Method, by Application, by Product and Geography, with Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Transfection Reagent and Equipment Market Definition
1.2 Global Transfection Reagent and Equipment Market Overview
1.3 Global Transfection Reagent and Equipment Market Segmentation
1.4 Research Scope of Transfection Reagent and Equipment Market in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Transfection Reagent and Equipment Market Systems Market
2.1 Market Definition
2.2 Industry Outlook
2.3 Value Chain Analysis
2.4 Industry Structure
2.5 Current Status & Trends
2.6 Demand & Supply Analysis
2.7 Trade Analysis
2.8 Price Trend Analysis
3. Global Transfection Reagent and Equipment Market Analysis
3.1 PEST Analysis of the Transfection Reagent and Equipment Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Transfection Reagent and Equipment Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.2 Supplier Power
3.9.3 Buyer Power
3.9.4 Threat of Substitute
3..9.5 Threat of New Entrant
4. Transfection Reagent and Equipment Market : Global Market Analysis by Segments
4.1 Global Transfection Reagent and Equipment Market Forecast, by Product 2020-2030
4.1.1 Product Overview
4.1.2 Reagents Market Forecast, 2020-2030
4.1.3 Equipment Market Forecast, 2020-2030
4.1.4 Other Product Market Forecast, 2020-2030
4.2 Global Transfection Reagent and Equipment Market Forecast, by Method 2020-2030
4.2.1 Method Overview
4.2.2 Electroporation Market Forecast, 2020-2030
4.2.3 Liposomes Market Forecast, 2020-2030
4.2.4 Particle Bombardment Market Forecast, 2020-2030
4.2.5 Microinjection Market Forecast, 2020-2030
4.2.6 Adenoviral Vectors Market Forecast, 2020-2030
4.2.7 Direct Microinjection Market Forecast, 2020-2030
4.2.8 Calcium phosphate Market Forecast, 2020-2030
4.2.9 DEAE - dextran Market Forecast, 2020-2030
4.2.10 Magnetic Beads Market Forecast, 2020-2030
4.2.11 Activated Dendrimers Market Forecast, 2020-2030
4.2.12 Laserfection Market Forecast, 2020-2030
4.2.13 Other Method Market Forecast, 2020-2030
4.3 Global Transfection Reagent and Equipment Market Forecast, by Application 2020-2030
4.3.1 Application Overview
4.3.2 Gene Expression Studies Market Forecast, 2020-2030
4.3.3 Protein Production Market Forecast, 2020-2030
4.3.4 Transgenic Models Market Forecast, 2020-2030
4.3.5 Therapeutic Delivery Market Forecast, 2020-2030
4.3.6 Cancer Research Market Forecast, 2020-2030
4.3.7 Biomedical Research Market Forecast, 2020-2030
4.3.8 Other Application Market Forecast, 2020-2030
5. Leading Regions in Transfection Reagent and Equipment Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Transfection Reagent and Equipment Market Forecast, 2020-2030
5.2.1 North America Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030
5.2.2 North America Transfection Reagent and Equipment Market Submarket, By Method Forecast 2020-2030
5.2.3 North America Transfection Reagent and Equipment Market Submarket, By Application Forecast 2020-2030
5.2.4 North America Transfection Reagent and Equipment Market Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Transfection Reagent and Equipment Market, Forecast 2020-2030
5.2.4.2 Canada Transfection Reagent and Equipment Market, Forecast 2020-2030
5.2.4.3 Mexico Transfection Reagent and Equipment Market, Forecast 2020-2030
5.3 Europe Transfection Reagent and Equipment Market Forecast, 2020-2030
5.3.1 Europe Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030
5.3.2 Europe Transfection Reagent and Equipment Market Submarket, By Method Forecast 2020-2030
5.3.3 Europe Transfection Reagent and Equipment Market Submarket, By Application Forecast 2020-2030
5.3.4 Europe Transfection Reagent and Equipment Market Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Transfection Reagent and Equipment Market, Forecast 2020-2030
5.3.4.2 Germany Transfection Reagent and Equipment Market, Forecast 2020-2030
5.3.4.3 France Transfection Reagent and Equipment Market, Forecast 2020-2030
5.3.4.4 Italy Transfection Reagent and Equipment Market, Forecast 2020-2030
5.3.4.5 Spain Transfection Reagent and Equipment Market, Forecast 2020-2030
5.3.4.6 The Netherlands Transfection Reagent and Equipment Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Transfection Reagent and Equipment Market, Forecast 2020-2030
5.4 Asia-Pacific Transfection Reagent and Equipment Market Forecast, 2020-2030
5.4.1 Asia-Pacific Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030
5.4.2 Asia-Pacific Transfection Reagent and Equipment Market Submarket, By Method Forecast 2020-2030
5.4.3 Asia-Pacific Transfection Reagent and Equipment Market Submarket, By Application Forecast 2020-2030
5.4.4 Asia-Pacific Transfection Reagent and Equipment Market Submarket, By Country Forecast 2020-2030
5.4.4.1 China Transfection Reagent and Equipment Market, Forecast 2020-2030
5.4.4.2 India Transfection Reagent and Equipment Market, Forecast 2020-2030
5.4.4.3 Japan Transfection Reagent and Equipment Market, Forecast 2020-2030
5.4.4.4 Korea Transfection Reagent and Equipment Market, Forecast 2020-2030
5.4.4.5 Indonesia Transfection Reagent and Equipment Market, Forecast 2020-2030
5.4.4.6 Australia Transfection Reagent and Equipment Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Transfection Reagent and Equipment Market, Forecast 2020-2030
5.5 Rest of World Transfection Reagent and Equipment Market Forecast, 2020-2030
5.5.1 Rest of World Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030
5.5.2 Rest of World Transfection Reagent and Equipment Market Submarket, By Method Forecast 2020-2030
5.5.3 Rest of World Transfection Reagent and Equipment Market Submarket, By Application Forecast 2020-2030
6. Leading Companies in The Transfection Reagent and Equipment Market
6.1 Mirus Bio LLC
6.1.1 Mirus Bio LLC Overview
6.1.2 Analysis of Mirus Bio LLC Products and Services
6.1.3 Mirus Bio LLC Primary Market Competitors 2019
6.1.4 Mirus Bio LLC Key Developments
6.2 EMD Millipore
6.2.1 EMD Millipore Company Overview
6.2.2 Analysis of EMD Millipore Products and Services
6.2.3 EMD Millipore Primary Market Competitors 2019
6.2.4 EMD Millipore Key Developments
6.3 Bio-Rad Laboratories Inc.
6.3.1 Bio-Rad Laboratories Inc. Company Overview
6.3.2 Analysis of Bio-Rad Laboratories Inc. Products and Services
6.3.3 Bio-Rad Laboratories Inc. Primary Market Competitors 2019
6.3.4 Bio-Rad Laboratories Inc. Key Developments
6.4 OriGene Technologies Inc
6.4.1 OriGene Technologies Inc Company Overview
6.4.2 Analysis of OriGene Technologies Inc Products and Services
6.4.3 OriGene Technologies Inc Primary Market Competitors 2019
6.4.4 OriGene Technologies Inc Key Developments
6.5 Merck KgaA
6.5.1 Merck KgaA Company Overview
6.5.2 Analysis of Merck KgaA Products and Services
6.5.3 Merck KgaA Primary Market Competitors 2019
6.5.4 Merck KgaA Key Developments
6.6 Merck KgaA
6.6.1 Merck KgaA Company Overview
6.6.2 Analysis of Merck KgaA Products and Services
6.6.3 Merck KgaA Primary Market Competitors 2019
6.6.4 Merck KgaA Key Developments
6.7 Promega Corporation
6.6.1 Promega Corporation Company Overview
6.6.2 Analysis of Promega Corporation Products and Services
6.6.3 Promega Corporation Primary Market Competitors 2019
6.6.4 Promega Corporation Key Developments
6.8 Lonza AG
6.8.1 Lonza AG Company Overview
6.8.2 Analysis of Lonza AG Products and Services
6.8.3 Lonza AG Primary Market Competitors 2019
6.8.4 Lonza AG Key Developments
6.9 Qiagen
6.9.1 Qiagen Company Overview
6.9.2 Analysis of Qiagen Products and Services
6.9.3 Qiagen Primary Market Competitors 2019
6.9.4 Qiagen Key Developments
6.10 F. Hoffmann-La Roche Ltd
6.10.1 F. Hoffmann-La Roche Ltd Company Overview
6.10.2 Analysis of F. Hoffmann-La Roche Ltd Products and Services
6.10.3 F. Hoffmann-La Roche Ltd Primary Market Competitors 2019
6.10.4 F. Hoffmann-La Roche Ltd Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Transfection Reagent and Equipment Market Segmentation
Figure 2.1 Transfection Reagent and Equipment Market Value Chain Analysis
Figure 3.1 Transfection Reagent and Equipment Market Supply-Demand Analysis
Figure 4.1 Global Transfection Reagent and Equipment Market Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Transfection Reagent and Equipment Market Forecast 2020-2030
Figure 4.3 Global Transfection Reagent and Equipment Market Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Transfection Reagent and Equipment Market By PRODUCT Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.19 Global Transfection Reagent and Equipment Market by Submarket By PRODUCT Forecast 2020-2030 ($ million)
Figure 4.20 Global Transfection Reagent and Equipment Market, by Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.21 Transfection Reagent and Equipment Market, By Method Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Transfection Reagent and Equipment Market, By Application System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Transfection Reagent and Equipment Market, By PRODUCT Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Transfection Reagent and Equipment Market, By Method Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Transfection Reagent and Equipment Market, by 2020-2030
Figure 5.3 Leading Country/Regional Transfection Reagent and Equipment Market Share, by 2020
Figure 5.4 Leading Country/Regional Transfection Reagent and Equipment Market Share, by 2025
Figure 5.5 Leading Country/Regional Transfection Reagent and Equipment Market Share, by 2030
Figure 5.6 Europe Transfection Reagent and Equipment Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Transfection Reagent and Equipment Market, by Forecast 2020-2030
Figure 5.8 Europe Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030
Figure 5.9 Europe Transfection Reagent and Equipment Market Submarket , By Method Forecast 2020-2030
Figure 5.10 Europe Transfection Reagent and Equipment Market Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Transfection Reagent and Equipment Market Submarket , By Application 2020-2030 ($billion, AGR%)
Figure 5.10 North America Transfection Reagent and Equipment Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Transfection Reagent and Equipment Market, by Forecast 2020-2030
Figure 5.12 North America Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030
Figure 5.13 North America Transfection Reagent and Equipment Market Submarket , By Method Forecast 2020-2030
Figure 5.14 North America Transfection Reagent and Equipment Market Submarket , By Application Forecast 2020-2030
Figure 5.13 North America Transfection Reagent and Equipment Market Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Transfection Reagent and Equipment Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Transfection Reagent and Equipment Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030
Figure 5.17 Asia-Pacific Transfection Reagent and Equipment Market Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Transfection Reagent and Equipment Market Submarket , By Application Forecast 2020-2030
Figure 5.18 Rest of World Transfection Reagent and Equipment Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Transfection Reagent and Equipment Market, by Forecast 2020-2030
Figure 5.20 Rest of World Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030
Figure 5.21 Rest of World Transfection Reagent and Equipment Market Submarket , By Method Forecast 2020-2030
Figure 5.21 Rest of World Transfection Reagent and Equipment Market Submarket , By Application Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 EMD Millipore Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Bio-Rad Laboratories Inc. Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 OriGene Technologies Inc Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 OriGene Technologies Inc Revenue % Share, by Application Segment, 2019
Figure 6.8 OriGene Technologies Inc Revenue % Share, by Geographical Trade, 2019
Figure 6.9 OriGene Technologies Inc Revenue % Share, by Business Segment, 2019
Figure 6.10 Merck KgaA Revenue % Share, by Geographic Segment, 2019
Figure 6.11 Merck KgaA Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 Promega Corporation Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 Promega Corporation Revenue % Share, by Regional Segment, 2019
Figure 6.14 Lonza AG Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 Lonza AG Revenue % Share, by Regional Segment, 2019
Figure 6.16 Lonza AG Revenue % Share, by Business Segment, 2019
Figure 6.17 Qiagen Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 F. Hoffmann-La Roche Ltd Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 F. Hoffmann-La Roche Ltd Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 F. Hoffmann-La Roche Ltd Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Transfection Reagent and Equipment Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Transfection Reagent and Equipment Market Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Transfection Reagent and Equipment Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Transfection Reagent and Equipment Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Transfection Reagent and Equipment Market Submarket, By Method Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Transfection Reagent and Equipment Market Submarket, By Application Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Transfection Reagent and Equipment Market Submarket, By Method Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Transfection Reagent and Equipment Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Transfection Reagent and Equipment Market Submarket, By Method Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Transfection Reagent and Equipment Market Submarket, By Application Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Transfection Reagent and Equipment Market Submarket, By PRODUCT Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Transfection Reagent and Equipment Market Submarket, By Method Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 EMD Millipore Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 EMD Millipore Products and Services (Product/Service, Segment)
Table 6.8 EMD Millipore Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 EMD Millipore Total Company Recent Development 2015-2019
Table 6.10 Bio-Rad Laboratories Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Bio-Rad Laboratories Inc. Products and Services (Product/Service, Segment)
Table 6.12 Bio-Rad Laboratories Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Bio-Rad Laboratories Inc. Total Company Recent Development 2015-2019
Table 6.14 OriGene Technologies Inc Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 OriGene Technologies Inc Products and Services (Product/Service, Segment)
Table 6.16 OriGene Technologies Inc Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 OriGene Technologies Inc Total Company Recent Development 2015-2019
Table 6.18 Merck KgaA Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Merck KgaA Products and Services (Product/Service, Segment)
Table 6.20 Merck KgaA Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Merck KgaA Total Company Recent Development 2015-2019
Table 6.22 Merck KgaA Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 Merck KgaA Products and Services (Product/Service, Segment)
Table 6.24 Merck KgaA Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 Merck KgaA Total Company Recent Development 2015-2019
Table 6.26 Promega Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 Promega Corporation Products and Services (Product/Service, Segment)
Table 6.28 Promega Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 Promega Corporation Total Company Recent Development 2015-2019
Table 6.30 Lonza AG Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 Lonza AG Products and Services (Product/Service, Segment)
Table 6.32 Lonza AG Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 Lonza AG Total Company Recent Development 2015-2019
Table 6.34 Qiagen Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Qiagen Products and Services (Product/Service, Segment)
Table 6.36 Qiagen Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Qiagen Total Company Recent Development 2015-2019
Table 6.38 F. Hoffmann-La Roche Ltd Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 F. Hoffmann-La Roche Ltd Products and Services (Product/Service, Segment)
Table 6.40 F. Hoffmann-La Roche Ltd Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 F. Hoffmann-La Roche Ltd Total Company Recent Development 2015-2019
Top Companies
Bio-Rad Laboratories Inc.
EMD Millipore
F. Hoffmann-La Roche Ltd
Lonza AG
Maxcyte, Inc.
Merck KgaA
Mirus Bio LLC
OriGene Technologies Inc
Promega Corporation
Qiagen
Thermo Fisher Scientific Inc
Other Companies
Genlantis, Inc.,
Life Technologies Corporation
MilliporeSigma
Polyplus-Transfection SA (Subsidary of Archimed)
Sigma-Aldrich
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
